Dr. Numan Khan, M.D.
What this data tells you about Dr. Khan
Dr. Numan Khan is an interventional cardiology in Houston, TX, with 11 years in practice. Based on federal Medicare data, Dr. Khan performed 2,810 Medicare services across 1,087 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khan received a total of $9,146 from 33 pharmaceutical and/or device companies across 170 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 1,120 | $0 | $4 |
| Office visit, established patient (30-39 min) | 355 | $98 | $190 |
| Hospital follow-up visit, moderate complexity | 283 | $62 | $176 |
| Regadenoson injection (Lexiscan) for heart stress test | 200 | $42 | $150 |
| Electrocardiogram (EKG), 12-lead | 154 | $11 | $77 |
| Echocardiogram, transthoracic | 78 | $143 | $800 |
| New patient office visit (45-59 min) | 65 | $128 | $275 |
| Initial hospital admission, moderate complexity | 64 | $100 | $200 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 57 | $55 | $535 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 50 | $1,934 | $7,500 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 50 | $651 | $830 |
| Nuclear medicine study of heart muscle blood flow by pet | 49 | $146 | $500 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 37 | $9 | $65 |
| Ultrasound of both sides of head and neck blood flow | 33 | $153 | $582 |
| Ultrasonic guidance for blood vessel access | 32 | $22 | $190 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 31 | $677 | $1,500 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 28 | $20 | $80 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 27 | $146 | $579 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 26 | $41 | $198 |
| Cardiac catheterization | 24 | $420 | $8,734 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 19 | $1,363 | $5,189 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 16 | $97 | $300 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 12 | $50 | $275 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Khan is a cardiac imaging specialist, with moderate Medicare volume, and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Khan experienced with contrast dye for imaging (iodine-based)?
Does Dr. Khan receive payments from pharmaceutical companies?
How do Dr. Khan's costs compare to other interventional cardiologys in Houston?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology